trending Market Intelligence /marketintelligence/en/news-insights/trending/IUud4rhRYL-400B-OW39jg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Canopy Growth closes C$60M bought-deal financing

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Canopy Growth closes C$60M bought-deal financing

Canopy Growth Corp. closed its bought-deal offering of 5,662,000 common shares priced at C$10.60 per share with gross proceeds of about C$60 million.

The company plans to use the proceeds primarily for potential real estate acquisitions and fit-up of growing operations at such locations. In case such potential acquisitions are not completed, the majority of the funds will be used to expand capacity at the company's existing sites over the next 12 months.

Canopy expects to incur international development expenditures of about C$2 million primarily to further explore and develop international market opportunities where federally legal to do so.

The balance of the net proceeds will be used for general working capital purposes, such as potential acquisitions for both capacity and brand augmentation and related integration, and developing new product offerings.

Canopy may reallocate these funds as market and regulatory indicators warrant in light of the anticipated legalization of a national recreational cannabis market and the Access to Cannabis for Medical Purposes Regulations (ACMPR).

The offering was underwritten by a syndicate of underwriters led by GMP Securities LP and Dundee Capital Partners, and including Cormark Securities Inc., PI Financial Corp. and Canaccord Genuity Corp. Separately, the company engaged Cowen and Co. LLC as financial adviser to provide financial advisory services in the U.S.